Similar Papers

Paper Title
Journal
Date
Author
ETV4‑mediated transcriptional activation of SLC12A5 exacerbates ferroptosis resistance and glucose metabolism reprogramming in breast cancer cells.
Huan Wang ... Fengxiang Wang
Molecular medicine reports | VOL. 30
Huan Wang, et. al.Huan Wang ... Fengxiang Wang
26 Sep 2024
Data from CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells
Ashwin Muruhadas ... Tracey D Bradshaw
-
Ashwin Muruhadas, et. al.Ashwin Muruhadas ... Tracey D Bradshaw
03 Apr 2023
CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells
Boon Shing Tan ... Malcolm F.G Stevens
Molecular Cancer Therapeutics | VOL. 10
Boon Shing Tan, et. al.Boon Shing Tan ... Malcolm F.G Stevens
01 Oct 2011
Data from CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells
Malcolm F.G Stevens ... Chee-Onn Leong
-
Malcolm F.G Stevens, et. al.Malcolm F.G Stevens ... Chee-Onn Leong
03 Apr 2023
View more papers

More From: Cancer communications (London, England)

Paper Title
Journal
Date
Author
Single-cell transcriptomics and epigenomics point to CD58-CD2 interaction in controlling primary melanoma growth and immunity.
Antonia Stubenvoll ... Manfred Kunz
Cancer communications (London, England) | VOL. -
Antonia Stubenvoll, et. al.Antonia Stubenvoll ... Manfred Kunz
15 Jan 2025
Targeting ferroptosis resistance resensitizes metastatic HR+HER2- breast cancer cells to palbociclib-hormone therapy.
Charles Pottier ... Nor Eddine Sounni
Cancer communications (London, England) | VOL. -
Charles Pottier, et. al.Charles Pottier ... Nor Eddine Sounni
13 Jan 2025
To what extent is the association between obesity and colorectal cancer risk mediated by systemic inflammation?
Fatemeh Safizadeh ... Hermann Brenner
Cancer communications (London, England) | VOL. -
Fatemeh Safizadeh, et. al.Fatemeh Safizadeh ... Hermann Brenner
10 Jan 2025
Efficacy and safety of first-line sintilimab plus anlotinib versus chemotherapy for metastatic non-small cell lung cancer: a phase II, open-label, randomized controlled trial.
Tianqing Chu ... Baohui Han
Cancer communications (London, England) | VOL. -
Tianqing Chu, et. al.Tianqing Chu ... Baohui Han
10 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.